SCHEMBL1100358

SCHEMBL1100358

Cc1c(N(CCC2CC2)S(=O)(=O)c2ccc(N3CCOCC3)cc2)sc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 6/20 0.41
RORC P51449 1/20 0.41
PKM P14618 1/20 0.39
TSHR P16473 1/20 0.39
CNR2 P34972 1/20 0.37
NPC1 O15118 1/20 0.36
PHOSPHO1 Q8TCT1 1/20 0.36
CASP3 P42574 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
HTR1A P08908 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR7 P34969 1/20 0.35
DRD3 P35462 1/20 0.35
HTR6 P50406 1/20 0.35
GAA P10253 1/20 0.35
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099902 0.92 CNR2 (0.46) TRPM8CNR2HTR1AHTR2AHTR2C
SCHEMBL1098150 0.91 TRPM8 (0.41) TRPM8RORCCNR2HTR1AHTR2A
SCHEMBL1100460 0.90 TRPM8 (0.41) TRPM8CNR2ALDH1A1HTR1AHTR2A
SCHEMBL1098232 0.85 TRPM8 (0.48) TRPM8CNR2MEN1KMT2AALDH1A1
SCHEMBL1098475 0.85 TRPM8 (0.43) TRPM8RORCPKMTSHRCNR2
SCHEMBL1099089 0.82 TRPM8 (0.44) TRPM8CNR2MEN1KMT2AHTR1A
SCHEMBL1099987 0.82 CA12 (0.37) TRPM8PKMMEN1KMT2AALDH1A1
SCHEMBL1099915 0.81 TRPM8 (0.43) TRPM8CNR2
SCHEMBL1099265 0.81 TRPM8 (0.61) TRPM8
SCHEMBL1099595 0.79 LMNA (0.48) TRPM8NPC1KMT2ARAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
CN-101801949-B Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2014-09-24 CN disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
CN-101801949-A Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2010-08-11 CN disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885RORC 3514/4885PKM 1256/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885RORC 3514/4885PKM 1256/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885RORC 3514/4885PKM 1256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.